Manufacturing: Page 6
-
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Outsourcing: Outsourcing For Efficiency
Outsourcing for Efficiency For many sponsor companies in the life-sciences industry engaging with outsourcing partners — from the clinic to the market — is imperative if they want to drive efficiencies in time, money, and personnel as well as innovation. Life-sciences companies can reap the many ...
By Taren Grom • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
C-Suite: Specialty Pharma
Specialty Pharma Targeted Opportunities C-Suite: Specialty Pharma By Taren Grom The growing U.S. specialty pharmaceuticals market is comprised of more than 90 companies marketing more than 550 prescription pharmaceutical products, according to MCD Group, and dozens of therapeutic categories, incl...
By Taren Grom • Jan. 28, 2013 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Saudi Arabia: Oil Wealth Opens Doors to Health and Life Sciences
Saudi Arabia: Oil Wealth Opens Doors to Health and Life Sciences By Kim Ribbink Its wealth, growing population, investment in health and the life sciences, and high rates of diseases such as diabetes, make Saudi Arabia an exciting market for pharma companies. Saudi Arabia is perhaps best known fo...
By Kim Ribbink • Jan. 28, 2013 -
PharmaVoice Team/PharmaVoice
Insights from the C-Suite: Pharmaceutical Companies
Insights from the C-Suite: Pharmaceutical CompaniesThe pharmaceutical industry is facing a number of well-publicized challenges: increasing generic competition, pricing pressures, innovation hurdles, Wall Street scrutiny, etc. C-suite pharmaceutical executives who were also featured in the Pharma...
By Taren Grom • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
Coming of Age: India Grows in Stature
India’s pharmaceutical industry is now the third largest in the world in terms of volume and stands 14th in terms of value. The country’s pharmaceutical market is expected to reach $55 billion in 2020 from $12.6 billion in 2009. And with a population of 1.1 billion, India is predicted to be the m...
By Kim Ribbink • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool executive appointments and promotions in the healthcare industry Pharmaceutical POOL Dr. Franck BARRAT Roche Broadens Inflammatory Expertise Franck Barrat, Ph.D., has joined Roche’s inflammation discovery and translational areas (DTA) as a distinguished scientist. Dr. Barrat brings ...
By PharmaVoice Team • July 28, 2012 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS Two colocated conferences produced by The Conference Forum will be held in Boston September 13-14. The 3rd Annual Executing Global Clinical Trials will focus on the strategies that will provide increased ...
By PharmaVoice Team • July 28, 2012 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Clinical Trial Solutions
SHOWCASE FEATURE: Clinical Trial Solutions Trials Without Tribulations By Carolyn Gretton As clinical studies become more global and increasingly complex, sponsors are striving to improve efficiencies, gain increased access to patients and investigators, and better integrate R&D competencies...
By PharmaVoice Team • May 29, 2012 -
PharmaVoice Team/PharmaVoice
Global Supply Chain: Information Drives Transformation
Robin Robinson Connecting directly with patients will be a new role for the supply chain function. There are a number of factors that are expected to reshape global supply chain processes, but none more than the onset of comparative effectiveness and the need to monitor and document patient out...
By Robin Robinson • April 27, 2012 -
PharmaVoice Team/PharmaVoice
The Sun Keeps Rising on Japan's Pharma Industry
Kim Ribbink Japan’s numerous universities and research institutions, cutting-edge research, state-of-the-art technology, and high-quality manufacturing facilities are the hallmarks of a leading market for the pharmaceutical industry. Japan is one of the world’s lead developers of pharmaceutica...
By Kim Ribbink • April 27, 2012 -
PharmaVoice Team/PharmaVoice
Market Capitalization
Effective marketing is at the heart of success for pharmaceutical brands and companies. And to get to the promised land, pharmaceutical companies around the globe are leveraging traditional and new media to sell and market their products. Most companies are faced with balancing myriad tactics to ...
By Taren Grom • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Creating the Message in Phase II Trials
Decisions made in Phase II trials can have an impact on the development and marketing program for new products, and experts say Phase II is becoming a critical stage for planning the potential launch and marketing of products. Bringing agencies in earlier in the process makes a lot of sense, says...
By Denise Myshko • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
What's Ahead for Biosimilars
Denise Myshko Uncertainty lies ahead for the biosimilar market, as manufacturers await FDA guidance. Biosimilars could represent a multi-billion dollar market in the United States, although some questions remain, including the uptake by physicians and payers, pricing of biosimilars, and how the F...
By Denise Myshko • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Talent Pool
executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Aaron BERG Essentialis Names CEO Essentialis, a pharmaceutical company focused on a novel medicine for the treatment of cardiovascular and metabolic disease, has promoted Aaron Berg to CEO, fro...
By Carolyn Gretton • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
New commercial models paying dividends… Creating value — the goal for all companies — and how they achieve this goal are as different as the companies themselves. According to a recent report — Strength in the Storm: How Biopharmaceutical and Medical Technology Companies Can Create Value in a Cha...
By Taren Grom • Jan. 26, 2012 -
PharmaVoice Team/PharmaVoice
Forecasting Pharma's Future
Forecasting Pharma’s Future Denise Myshko Given the volatility of today’s financial landscape, companies, more than ever, need a robust forecasting strategy that is clear, effective, and accurate. As companies seek to negotiate the volatility of emerging markets, the uncertainties of healthcare ...
By Denise Myshko • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
The Year of the Extreme Makeover
Every sector in the industry is in a state of flux. In this special issue of PharmaVOICE, more than 160 thought leaders throughout the life-sciences industry discuss the changing market dynamics. According to PricewaterhouseCooper’s 14th Annual Global CEO Survey, which looks at the concerns expre...
By Denise Myshko and Robin Robinsons • Nov. 11, 2011 -
PharmaVoice Team/PharmaVoice
Hola Mexico: Pharma Drawn to U.S. Neighbor
By Kim Ribbin Growing health coverage, high medical standards, a motivated patient population, and huge geographic advantages make Mexico an appealing market for the pharmaceutical industry. With a population of around 110 million people and a growing focus on healthcare, Mexico has fast becom...
By Kim Ribbink • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Dr. Tomas BOCANEGRA Pozen Appoints Development VP Pozen, a pharmaceutical company committed to developing medicines that transform lives, has named Tomas Bocanegra, M.D., executive VP of develo...
By PharmaVoice Team • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Merhaba, Turkey: Opportunity Knocks
As the largest pharmaceutical market in the Middle East and the fastest growing in the Mediterranean region, Turkey presents some exciting opportunities for the pharmaceutical market. Consumption of pharmaceuticals in Turkey totals around $8 billion, with 50% of these drugs being manufactured dom...
By Kim Ribbink • May 24, 2011 -
PharmaVoice Team/PharmaVoice
DIA Preview
New Tools, Services, and Products Designed to Improve Drug Development This special Drug Information Association section highlights the new and innovative products being offered by companies exhibiting at the upcoming 2011 DIA — 47th Annual Meeting in Chicago. (Note: briefs are listed alphabetic...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
CSR Gets a Makeover
Corporate social responsibility (CSR) policies have been in place for decades at most companies, but the increased social awareness of today’s consumers has stepped up the visibility of such programs. The state of the world’s economy, the ever-evolving business environment, and an overall growth ...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
HBA's 2011: Rising Stars
These high-potential women, who represent all facets and disciplines of the life-sciences industry, are being recognized by their companies for: Significantly contributing to their organizations. Exemplifying true leadership and acting as a role model for others. Assisting those in subordinat...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Honing the Edge
“Almost 70% of companies participating in a recent study use a decentralized market research structure, and yet often don’t provide training for the skills that make cross-functional decentralized structures work." Market research, long a key component of success in most pharma operations and s...
By Carolyn Gretton • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Ahn Nyeong: South Korea Emerges
In just three years, South Korea has been reclassified from an emerging market to a developed market by IMS. This is based on South Korea’s GDP level, as well as a well-established and growing economy, rising income levels, better living conditions, and an improved healthcare system that has led ...
By Kim Ribbink • April 25, 2011
Previous
